PROGRAM

The International Workshop on HIV Transmission seeks to improve the understanding of the HIV virus and its ability to infiltrate the global community. By providing an international interactive platform for clinicians, researchers, and other experts in the field of HIV, the workshop enables in-depth discussion and debate on all relevant mechanisms of HIV transmission. Experts can then integrate knowledge gained through this conference into their daily practice or continuing research in order to better combat the continued spread of this epidemic. 

notebook-2386034_1920

 
Program start at: 6:00 AM PST/ 9:00 AM EST/ 3:00 PM CET

 

 Thursday, 10 December 2020

  Welcome, Introductions and Goals
 Session 1: Ending the HIV Epidemic (EHE) in the US
  

Introduction on EHE
John Brooks
CDC, USA

  Testing
Jeffrey A. Johnson
CDC, USA
  Treatment
Roy (Trip) Gulick
Weill Cornell Medical College and New York-Presbyterian Hospital, USA
  PrEP
tbc
  Cluster Detection and Response
Alexa Oster
CDC, USA
  Roundtable Discussion and Q/A With All Session Speakers
  Coffee Break
 Session 2: Immune-Mediated Prevention of HIV Transmission
  European Vaccine Project
tbc
  

Vaccine Trials - What Went Wrong with the Vaccine Trial (HVTN 702)
tbc

  Antibody-Mediated Prevention Trials
Myron (Mike) Cohen
University of North Carolina, USA
  Abstract driven presentations
  Roundtable Discussion and Q/A With All Session Speakers
  End of Day 1
 

Friday, 11 December 2020

   Welcome, Introductions and Goals
 Session 3: Cellular Targets for Transmission 
  

Investigating the early interactions of HIV with its mucosal immune target cells relevant to sexual transmission

Anthony Cunningham & Andrew Harman
University of Sydney, Australia

   Mucosal Involvement in Transmission
tbc
  Abstract driven presentations
  Roundtable Discussion and Q/A With All Session Speakers
  Coffee Break
 Session 4: Animal Models for PrEP and Vaccine 
  Non-human Primate Preclinical Model for PrEP
Gerardo Garcia Lerma
CDC, USA
  Potential role for Tissue Resident Memory cells in a protective vaccine against HIV
David Masopust
University of Minnesota, USA
  Abstract driven presentations
  Roundtable Discussion and Q/A With All Session Speakers
  Summary and Closure of Program
  End of Day 2
  Feedback by Participants